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PRELIMINARY AND SHORT REPORTS
A NEW ANTIFUNGAL PRINCIPLE PRODUCED BY STREPTOMYCES FRADIAE*
WILFRED E. WOOLDEIDGE, M.D. AND MARY HOFFMAN, A.B.
In 1949 Waksman and Leehevalier (1) reported the discovery of an antibiotic derived
from Streptomyees fradiae. This antibiotic was named Neomycin and has been found active
against a wide variety of both gram positive and gram negative bacteria and particularly
TABLE I
Results of serial dilutions of "Neomycin" set against a variety of pathogenic fungi
CONCENTRATION OF "NEOMYCIN" SOLUTION IN UNITS PER CC.
ORGANISM
1000 .S50 250 100 50 25 10 5 2. 5 1.0 0.5 0.1 Con-trol
Nocardia braziliensis — — — — — — — — — — — + +
Phialophora verrucosa — — — — — — — — — + + + +
Blastomyces dermatitidis... + + + +
Phialophorapedrosoi — — — — — — — — + + + + +
Histoplasmacapsulatum.... + + + + + +
Nocardia madurae — — — — — — + + + + + + +
Nocardiaasteroides — — — — — + + + + + + + +
Coecidioidesimmitis + + + + + + + +
Phialophora jeanselmei — — — + + + + + + + + + +
Epidormophyton floecosum. — — — + + + + + + + + + +
Sporotriehumsehenki — + + + + + + + + + + + +
Aehorionsehoenleini — + + + + + + + + + + + +
Mierosporonaudouini — + + + + + + + + + + t +
Mierosporongypseum + + + + + + + + + + + + +
Mierosporoneanis ++++++++++++ +
Moniliaalbieans + + + + + + + + + + + + +Cryptoeoecus neoformans.. + + + + + + + + + + + + +
Paraeoeeidioides cerebre-
formis + + + + + + + + + + + + +
Triehophyton mentagro-
phytes ++++++++++++ +
Trichopbytonlaetieolor + + + + + + + + + + + + +Triehophyton purpureum... + + + + + + + + + + + + +
— Indicates fungicidal activity.
— Indicates no growth.
+ Indicates growth.
against mycobacteria but ineffective against all types of fungi except selected actinomy-
cetes. More recently Swart, Romano and Waksmaa (2) have discovered a second antibiotic
* Studies, observations and reports from the Research Laboratory, St. John's Hospital,
Springfield, Missouri and the Department of Dermatology of the Barnard Free Skin and
Cancer Hospital and Washington University School of Medicine, service of Dr. Richard S.
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produced by Streptomyces fradiae which is effective against a variety of fungi hut having
no antibacterial properties. This antibiotic they have called Fradicin.
In view of the stated effectiveness of ncomycin against actinomycetes, we have recently
assayed neomycin against several of those organisms as well as against a representative
selection of other pathogenic fungi. The neomycin was supplied by the Commercial Solvents
Corporation and consisted of two separate lots, one having a potency of 174 units per mg.
and the other, 185 units per mg.
PLATE 1. Pour plates showing inhibitory zones surrounding a cylinder filled with neo-
mycin solution, potency 1000 units per cubic ccntimeter Upper left, Nocardia braziliensis.
Upper right, Nocardia madurae. Lower left, Phialophora verrucosa. Lower right, Phialo-
phora pedrosoi.
The technic of assay was carried out by a serial tube dilution of the antibiotic
in Sabouraud's broth. The last tube of each series was the control tube of broth alone.
Following dilution, a fragment of a stock culture of the organism to be tested was placed
in each tube. These cultures were all recently obtained from clinical material. Growth, or
lack of growth, was noted and recorded at two or three day intervals. Sufficient time was
allowed for each organism to reach its full growth and final readings were made at seven to
eighteen days depending on the rapidity of growth. No additional amount of antibiotic
was added subsequently to compensate for deterioration of the antibiotic in solution.
As a check on the above technic, pour plates were also made with a suspension of the
organisms in melted Sabouraud's agar. After 2 days, in which to allow for the organisms to
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become well established, an antibiotic assay tube was imbedded in the center of each Petri
dish and the tube was filled with the "neomycin" solution containing 1000 units per cc.
Growth was then allowed to occur without any further interference.
In the performance of these assays it was fonnd, as expected, that the neomycin con-
tained a powerful principle which was not only fungistatic but also fungicidal for the
actinomycetes tested. To our considerable surprise, there was also an equally powerful
effect on several other assayed species: all of them the so-called "deep" fungi. There was
no effect on the yeast-like organisms and no effect which was significant on any of the
dermatophytes. These data are presented in detail in Table I. It was found that there was
a slowing of growth of almost every organism tested. This was proportional to the concen-
tration of the antibiotic. Plate 1 shows pour plates with zones of inhibition surrounding a
cylinder filled with a "neomycin" solution.
DISCUSSION
Efforts are being made at this time to isolate and purify this antibiotic. For the present,
little is known regarding it other than that it appears certain not to be the neomycin de-
scribed by Waksman. The spectrum of the original neomycin has been repeatedly deter-
mined and its antifungal properties would have been realized previously. It is also possible
that our newly discovered antibiotic either is toxic itself or is accompanied by a toxic
substance as the lots of neomycin containing this principle have possessed an unexplained
nephrotoxicity not found in others.
To prevent an excessive burden of nomenclature regarding the antibiotics derived from
Streptomyces fradiae it would seem advisable to follow the course adopted in the case of
polymyxin and penicillin. Perhaps the original neomycin could be termed "Neomycin A";
the Fradicin of Swart, "Neomycin B"; and the antibiotic presented here, "Neomycin C".
SUMMARY
(1) The discovery of a new antifungal principle of Streptomyces fradiae is presented.
This antibiotic is effective in vitro against several aerobic actinomycetes as well as numer-
ous of the "deep" fungi. The dermatophytes as well as two yeast-like organisms are not
affected.
(2) It is thought that this antibiotic is entirely separate from the original neomycin of
Waksman and also from the more recently discovered Fradicin of Swart and his co-workers.
(3) A simplification of nomenclature regarding the antibiotics derived from Strep-
tomyces fradiae is suggested.
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